Innovent Biologics Pink Sheet Forecast - Price Action Indicator

IVBXF Stock  USD 4.85  0.24  4.72%   
Innovent Pink Sheet Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Innovent Biologics' historical fundamentals, such as revenue growth or operating cash flow patterns.
  
Innovent Biologics has current Price Action Indicator of (0.12). Price Action indicator evaluates an asset for a given trading period using the following formula: ((close - open) + (close - high) + (close - low)) / 2. This indicator is consistent with the interpretation of Japanese candlestick patterns.
Check Innovent Biologics VolatilityBacktest Innovent BiologicsInformation Ratio  

Innovent Biologics Trading Date Momentum

On November 23 2024 Innovent Biologics was traded for  4.85  at the closing time. The highest daily price throughout the period was 4.85  and the lowest price was  4.85 . There was no trading activity during the period 0.0. Lack of trading volume on 11/23/2024 did not cause price change. The trading delta at closing time to current closing price is 0.00% .
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
Compare Innovent Biologics to competition

Other Forecasting Options for Innovent Biologics

For every potential investor in Innovent, whether a beginner or expert, Innovent Biologics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Innovent Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Innovent. Basic forecasting techniques help filter out the noise by identifying Innovent Biologics' price trends.

View Innovent Biologics Related Equities

 Risk & Return  Correlation

Innovent Biologics Technical and Predictive Analytics

The pink sheet market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Innovent Biologics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Innovent Biologics' current price.

Innovent Biologics Market Strength Events

Market strength indicators help investors to evaluate how Innovent Biologics pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Innovent Biologics shares will generate the highest return on investment. By undertsting and applying Innovent Biologics pink sheet market strength indicators, traders can identify Innovent Biologics entry and exit signals to maximize returns.

Innovent Biologics Risk Indicators

The analysis of Innovent Biologics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Innovent Biologics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting innovent pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Currently Active Assets on Macroaxis

Other Information on Investing in Innovent Pink Sheet

Innovent Biologics financial ratios help investors to determine whether Innovent Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Innovent with respect to the benefits of owning Innovent Biologics security.